0

Back to Use of a Blast Dominance–Hematogone Index for the Flow Cytometric Evaluation of Myelodysplastic Syndrome (MDS)
Use of a Blast Dominance–Hematogone Index for the Flow Cytometric Evaluation of Myelodysplastic Syndrome (MDS)

Use of a Blast Dominance–Hematogone Index for the Flow Cytometric Evaluation of Myelodysplastic Syndrome (MDS)

Online journal article in Hematopathology that offers 1.0 continuing education (CME/SAM) credit that can be used to fulfill CC Part II requirements.

  • List Price: $20.00
  • Member Price: $15.00
 
Want to save more?
Log into see if you qualify for a lower rate.
Members save $5.00 or more Join
Item Details:
Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, you will be able to:

  • describe the historical limitations of flow cytometry in diagnosing myelodysplastic syndrome (MDS).
  • define the key immunophenotypic markers used to track...
Back to Use of a Blast Dominance–Hematogone Index for the Flow Cytometric Evaluation of Myelodysplastic Syndrome (MDS)
View More View Less